Phase 3 Study Confirms Strong Safety and Immunogenicity of EuTYPH-C Inj.® Multi-Dose
In a landmark advancement for global public health, the Phase 3 clinical trial results of EuTYPH-C Inj.® Multi-dose, a typhoid conjugate vaccine (TCV) developed by...
















